中国提供全球卫生公共产品的路径分析——以中国援助西非国家抗击埃博拉疫情为例

发布时间：2018-04-17 00:24

本文选题：全球卫生公共产品 + 国际公共卫生治理体系　；参考：《国际观察》2017年05期

【摘要】：2013-2016年西非埃博拉疫情的爆发和流行凸现了全球卫生公共产品供给的严重不足。面对西非国家防控埃博拉疫情突发的紧急需求,中国政府予以高度重视并积极从多个方面提供全球卫生公共产品——中国医药专家全力参加埃博拉病毒诊断试剂和治疗药物等的研制,中国政府向多个西非国家提供紧急物资和资金援助,同时支持和参与以世界卫生组织和联合国为核心的国际公共卫生治理多边体系。然而,从提供全球卫生公共产品的角度看,中国国内防控传染病的能力尚有待提升,中国非政府组织和企业参与国际传染病防控行动的意愿亟需引导和鼓励,中国对国际公共卫生治理多边体系的参与度和贡献还应进一步提高。由此,中国在全球卫生治理领域的领导力和国际声誉才会得以提高和彰显。
[Abstract]:The outbreak and epidemic of Ebola in West Africa in 2013-2016 highlighted a serious shortfall in the global supply of public health goods.In the face of the emergency needs of West African countries to prevent and control the Ebola epidemic,The Chinese government attaches great importance to it and actively provides global public health products from many aspects. Chinese medical experts are fully involved in the development of Ebola virus diagnostic reagents and therapeutic drugs.The Chinese government provides emergency material and financial assistance to several West African countries, while supporting and participating in the multilateral system of international public health governance with the World Health Organization and the United Nations as the core.However, from the point of view of providing global health public goods, the ability of China to prevent and control infectious diseases needs to be improved, and the willingness of Chinese non-governmental organizations and enterprises to participate in the international action to prevent and control infectious diseases needs to be guided and encouraged.China's participation and contribution to the multilateral system of international public health governance should be further enhanced.As a result, China's leadership and international reputation in global health governance will be enhanced and demonstrated.
【作者单位】：上海政法学院国际事务与公共管理学院;
【基金】：上海政法学院“一带一路”安全研究及创新性学科团队项目上海市法学高原学科(国际法与国际政治方向)和国家社科基金重大项目“习近平治国理念之外交战略思想研究”(项目编号:15ZDC002)的阶段性成果
【分类号】：D822.343;R512.8

【相似文献】